z-logo
Premium
Cysticercosis as a Major Risk Factor for Epilepsy in Burundi, East Africa
Author(s) -
Nsengiyumva Georges,
DruetCabanac Michel,
Ramanankandrasana Bienvenue,
Bouteille Bernard,
Nsizabira Léopold,
Preux PierreMarie
Publication year - 2003
Publication title -
epilepsia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.687
H-Index - 191
eISSN - 1528-1167
pISSN - 0013-9580
DOI - 10.1046/j.1528-1157.2003.55302.x
Subject(s) - cysticercosis , neurocysticercosis , taenia solium , epilepsy , odds ratio , medicine , confidence interval , risk factor , population , case control study , pediatrics , helminthiasis , immunology , environmental health , pathology , psychiatry
Summary:  Purpose: Human cysticercosis is a direct consequence of infection by Taenia solium larvae ( Cysticercus cellulosae ). Results of studies on the impact of neurocysticercosis on epilepsy in Africa are inconsistent. The objective was to evaluate the role of cysticercosis in epilepsy in Burundi. Methods: A prevalent matched case–control design was used in the Kiremba area, Burundi, between March and April 2001. One case with epilepsy was matched to two control subjects, according to their age. Cases were subjects who had shown at least two unprovoked epileptic seizures within a 24‐h time range and who lived in the Kiremba area. The control subjects also lived in Kiremba and had neither neurologic illness nor kinship with the people with epilepsy. Seropositivity for cysticercosis was the exposure variable. Three hundred twenty‐four prevalent cases, with onset of epilepsy between 1950 and 2000, and 648 age‐matched controls were included. Results: This study found a link between cysticercosis infestation and the occurrence of epilepsy (odds ratio, 3.8; 95% confidence interval, 2.5–5.1). Conclusions: The study highlighted the importance of cysticercosis in the area of Kiremba, as 31.5% of the control subjects screened positive for this parasite. The attributable risk for cysticercosis was 50% (95% confidence interval, 42–57) in this population.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here